Friday, July 31, 2026

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

South Korea-China Summit…Economic ‘Results’ Ban Action of South Korean Culture, Yellow-Sea Stuctures ‘Advencements’ North Korea, Nuclear Submarine ‘Suspension’

South Korea and China enhance cooperation through 14 MOUs, addressing cultural imports and regional peace, while navigating sensitive issues.

Kim Jong Un’s 2026 Power Play: Key Appointments in North Korea’s Political Landscape

North Korea has reshuffled its leadership, re-electing Kim Jong Un and appointing key officials, solidifying his control over the party and military.

Tag: Keytruda

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.